Even when NPM1mut is tightly associated with de novo AML, on rare occasions, NPM1 mutations can emerge in other myeloid neoplasms as secondary mutations, ultimately contributing to the development of AML, as suggested by clinical studies [4,27] and mouse models [28]. This evidence concerns the gene NPM1 and acute myeloid leukemia.